Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Org 48762-0 50mg | 755753-89-0 | 50 MG
SDP

Catalog No. 5000227006
Encompass_Preferred

Org 48762-0 (UR13870) is a potent, orally active, and selective p38 MAP kinase inhibitor used in research to study inflammatory signaling and cytokine production. It inhibits p38α kinase with low-nanomolar potency in biochemical assays and reduces LPS-induced TNFα release in cellular and animal models.

  • Potent p38α/p38β inhibition (EC50 0.1 μM).
  • Reduces LPS-induced TNFα release in PBMCs (EC50 0.06 μM).
  • Orally bioavailable with demonstrated systemic exposure in mice.
  • High reported purity suitable for biochemical and cellular assays.
  • Stable as a powder at -20°C for long-term storage.

Catalog No. 50-002-27006 Supplier Medchemexpress LLC Supplier No. HY11422150MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Org 48762-0 (UR13870) is a potent, orally active, and selective p38 MAP kinase inhibitor used in research to study inflammatory signaling and cytokine production. It inhibits p38α kinase with low-nanomolar potency in biochemical assays and reduces LPS-induced TNFα release in cellular and animal models.

  • Potent p38α/p38β inhibition (EC50 0.1 μM).
  • Reduces LPS-induced TNFα release in PBMCs (EC50 0.06 μM).
  • Orally bioavailable with demonstrated systemic exposure in mice.
  • High reported purity suitable for biochemical and cellular assays.
  • Stable as a powder at -20°C for long-term storage.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.